Crystal Structure of Bisphosphorylated IGF-1 Receptor Kinase

Alexander Pautsch(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Horst Ahorn(Boehringer Ingelheim (Austria)), Andreas Zoephel(Boehringer Ingelheim (Austria)), Walter Spevak(Boehringer Ingelheim (Austria)), Rudolf Hauptmann(Boehringer Ingelheim (Austria))
Structure
October 1, 2001
10.1016/s0969-2126(01)00655-4
Cited by 94

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285